Group by: Item Type | Date | No Grouping
Number of items: 2.

Richardson, Tim ORCID: 0009-0006-3588-6376, Schütte, Daniel ORCID: 0000-0002-4746-537X, Kobbe, Guido, Baermann, Ben-Niklas, Holderried, Tobias A. W. ORCID: 0000-0002-2474-523X, Schmitz, Friederike ORCID: 0000-0002-5271-1088, Crysandt, Martina, Hallek, Michael ORCID: 0000-0002-7425-4455, Scheid, Christoph ORCID: 0009-0007-6539-226X, Holtick, Udo ORCID: 0000-0002-5543-0257, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Stemler, Jannik ORCID: 0000-0001-9152-2469 and Mellinghoff, Sibylle C. ORCID: 0000-0003-3928-2503 (2025). Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis. Blood Advances, 9 (6). pp. 1370-1375. Elsevier. ISSN 2473-9529

Richardson, Tim ORCID: 0009-0006-3588-6376, Tharmaseelan, Hishan ORCID: 0009-0002-5680-8714, Kobbe, Guido ORCID: 0000-0002-9745-8813, Baermann, Ben‐Niklas ORCID: 0009-0000-1699-9478, Holderried, Tobias A. W. ORCID: 0000-0002-2474-523X, Schmitz, Friederike ORCID: 0000-0002-5271-1088, Crysandt, Martina ORCID: 0000-0002-7450-3394, Gödel, Philipp ORCID: 0000-0001-7887-8313, Wolfensberger, Nathan, Schütte, Daniel, Hallek, Michael ORCID: 0000-0002-7425-4455, Scheid, Christof ORCID: 0009-0007-6539-226X and Holtick, Udo ORCID: 0000-0002-5543-0257 (2025). Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells. eJHaem, 6 (5). pp. 1-5. Wiley. ISSN 2688-6146

This list was generated on Thu Apr 16 16:58:21 2026 CEST.